NASDAQ:NK
Delisted
NantKwest Stock News
$6.55
+0 (+0%)
At Close: Aug 17, 2022
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
Hospital led by biotech billionaire Soon-Shiong approved for PPP aid
12:00am, Tuesday, 07'th Jul 2020
Hospital led by biotech billionaire Soon-Shiong approved for PPP aid
Weekly CEO Buys Highlight
02:48pm, Monday, 06'th Jul 2020
Details the CEO buys this past week for NantKwest and Gray Television Continue reading...
State Street Corp Sells 3,520 Shares of Nantkwest Inc (NASDAQ:NK)
04:02am, Sunday, 05'th Jul 2020
State Street Corp lessened its position in shares of Nantkwest Inc (NASDAQ:NK) by 25.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
The Executive Chairman & CEO of NantKwest, Inc. (NASDAQ:NK), Patrick Soon-Shiong, Just Bought 6.1% More Shares
02:24pm, Thursday, 02'nd Jul 2020
Those following along with NantKwest, Inc. (NASDAQ:NK) will no doubt be intrigued by the recent purchase of shares by...
Insider Buying: Nantkwest Inc (NASDAQ:NK) CEO Acquires 3,710,000 Shares of Stock
04:20am, Wednesday, 01'st Jul 2020
Nantkwest Inc (NASDAQ:NK) CEO Patrick Soon-Shiong purchased 3,710,000 shares of the firm’s stock in a transaction that occurred on Monday, June 29th. The shares were bought at an average price of $1
6 Stocks That Could Shoot Higher
12:00am, Wednesday, 01'st Jul 2020
Stocks Analysis by Harry Boxer covering: Crocs Inc, Tesla Inc, Celldex Therapeutics Inc, GenMark Diagnostics Inc. Read Harry Boxer's latest article on Investing.com
7 Stocks That Could Jump Higher
12:00am, Tuesday, 30'th Jun 2020
Stocks Analysis by Harry Boxer covering: Boeing Co, Bed Bath & Beyond Inc, Ballard Power Systems Inc, Fluidigm Corporation. Read Harry Boxer's latest article on Investing.com
NantKwest: The Market And The Government Are Missing Out On This Blockbuster
09:37pm, Monday, 29'th Jun 2020
NantKwest recently revealed impressive results for their PD-L1 t-haNK product candidate across 15 solid tumor types. The company revealed their specialized NK c
NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, announced today the closing of its previously announced underwritten public offering of an aggregate of
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
06:06pm, Monday, 29'th Jun 2020
Inovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars in funding to scale up manufacturing capaci
Barry J. Simon Sells 29,609 Shares of Nantkwest Inc (NASDAQ:NK) Stock
06:45am, Friday, 26'th Jun 2020
Nantkwest Inc (NASDAQ:NK) insider Barry J. Simon sold 29,609 shares of the stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $13.01, for a total value of $38
Nantkwest (NASDAQ:NK) Shares Gap Up to $11.80
06:06am, Friday, 26'th Jun 2020
Nantkwest Inc (NASDAQ:NK) gapped up prior to trading on Wednesday . The stock had previously closed at $12.18, but opened at $11.80. Nantkwest shares last traded at $11.80, with a volume of 1,385,575
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
11:37am, Thursday, 25'th Jun 2020
Inovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars...
